共 84 条
[1]
Antman EM(2000)The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 835-842
[2]
Cohen M(2002)Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups Circulation 106 1622-1626
[3]
Bernink PJ(2002)Identification of patients at high risk for death and cardiac ischemic events after hospital discharge Am Heart J 143 966-970
[4]
Budaj A(2002)An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS Eur Heart J 23 223-229
[5]
Yusuf S(2002)Validation of the Thrombolysis in Myocardial Infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry Am J Cardiol 90 303-305
[6]
Mehta SR(2006)Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population Acad Emerg Med 13 13-18
[7]
Sabatine MS(1991)Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room Am J Cardiol 68 171-175
[8]
McCabe CH(1991)Three-year mortality in patients suspected of acute myocardial infarction with and without confirmed diagnosis. The Danish Study Group on Verapamil in Myocardial Infarction Am Heart J 122 1270-1273
[9]
Morrow DA(2001)Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I Circulation 104 1483-1488
[10]
Morrow DA(1999)Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial Am J Cardiol 83 317-322